Screening for Gestational Diabetes Mellitus: Are the Criteria Proposed by the International Association of the Diabetes and Pregnancy Study Groups Cost-Effective?
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The International Association of the Diabetes and Pregnancy Study Groups (IADPSG) recently recommended new criteria for diagnosing gestational diabetes mellitus (GDM). This study was undertaken to determine whether adopting the IADPSG criteria would be cost-effective, compared with the current standard of care. RESEARCH DESIGN AND METHODS: We developed a decision analysis model comparing the cost-utility of three strategies to identify GDM: 1) no screening, 2) current screening practice (1-h 50-g glucose challenge test between 24 and 28 weeks followed by 3-h 100-g glucose tolerance test when indicated), or 3) screening practice proposed by the IADPSG. Assumptions included that 1) women diagnosed with GDM received additional prenatal monitoring, mitigating the risks of preeclampsia, shoulder dystocia, and birth injury; and 2) GDM women had opportunity for intensive postdelivery counseling and behavior modification to reduce future diabetes risks. The primary outcome measure was the incremental cost-effectiveness ratio (ICER). RESULTS: Our model demonstrates that the IADPSG recommendations are cost-effective only when postdelivery care reduces diabetes incidence. For every 100,000 women screened, 6,178 quality-adjusted life-years (QALYs) are gained, at a cost of $125,633,826. The ICER for the IADPSG strategy compared with the current standard was $20,336 per QALY gained. When postdelivery care was not accomplished, the IADPSG strategy was no longer cost-effective. These results were robust in sensitivity analyses. CONCLUSIONS: The IADPSG recommendation for glucose screening in pregnancy is cost-effective. The model is most sensitive to the likelihood of preventing future diabetes in patients identified with GDM using postdelivery counseling and intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The current criteria for the diagnosis of GDM introduced by The International Association of Diabetes and Pregnancy Study Groups (IADPSG), which were based on the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) results, found a threefold increase in GDM diagnoses, which suggests an earlier underestimation.”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [27]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The HAPO study demonstrated a positive linear relationship between screening glucose values and adverse perinatal outcomes. Moreover, the study authors found that perinatal risks began to increase in women with glucose values that were previously considered “normal” [27,28].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [27]
In the citing paper
“In a comparison of the 1-step with the 2-step protocols, 38 the 1-step protocol was predicted to be more costeffective than the 2-step protocol if GDMs receive postdelivery intensive counseling and care to prevent type 2 diabetes.”
From One-step or 2-step testing for gestational diabetes: which is better? (2021) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
ACOG Practice Bulletin No. 30: Gestational Diabetes
(2001) · Obstetrics & Gynecology · doi:10.1097/00006250-200109000-00037 · Cited by 301
Retracted- Retracted
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
Diabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020
A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122
Metzger, B. E., Gabbe, S. G., Persson, B., Lowe, L. P., Dyer, A. R., Oats, J. J. N., & Buchanan, T. A. (2010) · Diabetes Care · doi:10.2337/dc10-0719 · Cited by 1,888
Gynecologists (2009) · Cited by 1,037
Ratner, R. E., Christophi, C. A., Metzger, B. E., Dabelea, D., Bennett, P. H., Pi-Sunyer, X., Fowler, S., Kahn, S. E., & The Diabetes Prevention Program Research Group (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0772 · Cited by 867
Weiss, P. (1988) · Cited by 780
Shiroiwa, T., Sung, Y., Fukuda, T., Lang, H., Bae, S., & Tsutani, K. (2010) · Health Economics · doi:10.1002/hec.1481 · Cited by 690 · cited 1×
“Although some debate exists in the literature, for this study an ICER of $100,000 was considered cost-effective (27).”
BackgroundCowie, C. C., Rust, K. F., Byrd-Holt, D. D., Gregg, E. W., Ford, E. S., Geiss, L. S., Bainbridge, K. E., & Fradkin, J. E. (2010) · Diabetes Care · doi:10.2337/dc09-1524 · Cited by 689
One Thousand Health-Related Quality-of-Life Estimates
Tengs, T. O., & Wallace, A. (2000) · Medical Care · doi:10.1097/00005650-200006000-00004 · Cited by 662 · cited 1×
“Utilities are a means to evaluate the relative quality of life as compared with health unfettered by disease (18).”
BackgroundRouse, D. J. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540180036030 · Cited by 496
Hyperglycemia and Adverse Pregnancy Outcomes: The HAPO Study Cooperative Research Group
(2008) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e318187b7a2 · Cited by 488
Martin, J. A., Hamilton, B. E., Sutton, P. D., Ventura, S. J., Mathews, T. J., Kirmeyer, S., & Osterman, M. J. K. (2010) · PubMed · Cited by 419
Franco, O. H., Steyerberg, E. W., Hu, F. B., Mackenbach, J., & Nusselder, W. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.11.1145 · Cited by 400 · cited 1×
“Life expectancy was shortened by 8 years in treated symptomatic diabetic patients and 9 years in untreated diabetic patients (20,22,26).”
BackgroundGestational diabetes mellitus: prevalence, risk factors, maternal and infant outcomes
Xiong, X., Saunders, L. D., Wang, F. L., & Demianczuk, N. N. (2001) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(01)00496-9 · Cited by 399
Valuing Health-Related Quality of Life in Diabetes
Coffey, J. T., Brandle, M., Zhou, H., Marriott, D., Burke, R., Tabaei, B. P., Engelgau, M. M., Kaplan, R. M., & Herman, W. H. (2002) · Diabetes Care · doi:10.2337/diacare.25.12.2238 · Cited by 379
The cost of prematurity: quantification by gestational age and birth weight
Gilbert, W. (2003) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(03)00617-3 · Cited by 369 · cited 1×
“Newborn nursery care 1,221 808–6,048 (38)”
Recent Trends in Cesarean Delivery in the United States: (665412010-001)
Menacker, F., & Hamilton, B. E. (2010) · PsycEXTRA Dataset · doi:10.1037/e665412010-001 · Cited by 367
Horvath, K., Koch, K., Jeitler, K., Matyas, E., Bender, R., Bastian, H., Lange, S., & Siebenhofer, A. (2010) · BMJ · doi:10.1136/bmj.c1395 · Cited by 359 · cited 2×
“Given a fixed risk of birth injury after shoulder dystocia, subsequent temporary and permanent birth injury would be reduced by GDM management (6).”
BackgroundThe Diabetes Prevention Program Research Group (2003) · Diabetes Care · doi:10.2337/diacare.26.1.36 · Cited by 358
Shoulder dystocia and associated risk factors with macrosomic infants born in California
Nesbitt, T. S., Gilbert, W. M., & Herrchen, B. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70382-5 · Cited by 315
Ray, J. G. (2001) · QJM · doi:10.1093/qjmed/94.7.347 · Cited by 233 · cited 1×
“8% for diabetes, cGDM, iGDM, and euglycemic women respectively (2,3,5,7) We estimated the frequency of shoulder dystocia at 5, 2.”
BackgroundTreatments for gestational diabetes
Alwan, N., Tuffnell, D. J., & West, J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003395.pub2 · Cited by 214
Improving Decision Analyses: Parent Preferences (Utility Values) for Pediatric Health Outcomes
Carroll, A. E., & Downs, S. M. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.01.040 · Cited by 210 · cited 3×
“Cesarean section 8,288 6,871–9,481 (25)”
BackgroundInfluentialSibai, B. M., Caritis, S. N., Hauth, J. C., MacPherson, C., VanDorsten, J. P., Klebanoff, M., Landon, M., Paul, R. H., Meis, P. J., Miodovnik, M., et al. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.107621 · Cited by 202
Bell, R., Bailey, K., Cresswell, T., Hawthorne, G., Critchley, J., Lewis‐Barned, N., & Northern Diabetic Pregnancy Survey Steering Group (2008) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2007.01644.x · Cited by 200
Universal cervical‐length screening to prevent preterm birth: a cost‐effectiveness analysis
Werner, E. F., Han, C. S., Pettker, C. M., Buhimschi, C. S., Copel, J. A., Funai, E. F., & Thung, S. F. (2011) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.8911 · Cited by 175 · cited 1×
“TheseQALYswere summed as has been done in other maternal/fetal cost-utility studies (19,20).”
ResultSelf-citationThe cost-effectiveness of screening for type 2 diabetes
The CDC Diabetes Cost-Effectiveness Study Group (1998) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.280.20.1757 · Cited by 175
The relationship between maternal glycemia and perinatal outcome
Landon, M. B., Mele, L., Spong, C. Y., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2011) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e318203ebe0 · Cited by 150
Thorpe, L. E., Berger, D., Ellis, J. A., Bettegowda, V. R., Brown, G., Matte, T., Bassett, M., & Frieden, T. R. (2005) · American Journal of Public Health · doi:10.2105/ajph.2005.066100 · Cited by 146 · cited 1×
“2% had GDM based on the IADPSG criteria (cGDM+iGDM) (2,10,12).”
MethodMeltzer, S., Snyder, J., Penrod, Jr., Nudi, M., & Morin, L. (2010) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2009.02475.x · Cited by 121 · cited 3×
“Serum glucose measurement 11 1–110 (28)”
BackgroundInfluentialThe challenge of fetal mortality: (565172009-001)
MacDorman, M. F., & Kirmeyer, S. (2009) · PsycEXTRA Dataset · doi:10.1037/e565172009-001 · Cited by 106
Moss, J. R., Crowther, C. A., Hiller, J. E., Willson, K. J., Robinson, J. S., & The Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group (2007) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-7-27 · Cited by 97 · cited 2×
“Several other studies have examined the cost-effectiveness of GDM treatment (29,30), but only in pregnancy.”
BackgroundCost-Effectiveness of a Trial of Labor After Previous Cesarean
CHUNG, A., Macario, A., El-Sayed, Y. Y., Riley, E. T., Duncan, B. W., & Druzin, M. L. (2001) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(01)01355-2 · Cited by 81 · cited 2×
“TheseQALYswere summed as has been done in other maternal/fetal cost-utility studies (19,20).”
BackgroundResultCulligan, P. J., Myers, J. A., Goldberg, R. P., Blackwell, L., Gohmann, S. F., & Abell, T. D. (2004) · International Urogynecology Journal · doi:10.1007/s00192-004-1203-3 · Cited by 64
Timing of elective repeat cesarean delivery at term and neonatal outcomes: a cost analysis
Robinson, C., Villers, M. S., Johnson, D., & Simpson, K. N. (2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.03.045 · Cited by 50 · cited 1×
“Neonatal intensive care 2,370 1,185–24,878 (37)”
Aljohani, N., Rempel, B. M., Ludwig, S. M., Morris, M., Cheang, M., Murray, R. A., Bruce, S. G., & Shen, G. X. (2008) · Clinical and investigative medicine · doi:10.25011/cim.v31i6.4919 · Cited by 45
Barton, J. R., Istwan, N. B., Rhea, D., Collins, A., & Stanziano, G. J. (2006) · Disease Management · doi:10.1089/dis.2006.9.236 · Cited by 39
Assessment of costs and benefits of management of gestational diabetes mellitus.
Kitzmiller, J. L., Elixhauser, A., Carr, S., Major, C. A., de Veciana, M., Dang-Kilduff, L., & Weschler, J. M. (1998) · PubMed · Cited by 30
Cited by
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s002 · Cited by 3,187
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s002 · Cited by 3,116
“counseling and care to prevent type 2 diabetes (196).”
Background2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
Stagnaro-Green, A., Abalovich, M., Alexander, E., Azizi, F., Mestman, J., Negro, R., Nixon, A., Pearce, E. N., Soldin, O. P., Sullivan, S., et al. (2011) · Thyroid · doi:10.1089/thy.2011.0087 · Cited by 2,942
Metadata
- Authors
- Werner, E. F., Pettker, C. M., Zuckerwise, L., Reel, M., Funai, E. F., Henderson, J., & Thung, S. F.
- Affiliations
- Johns Hopkins University (US)
- Yale University (US)
- The Ohio State University (US)
- Corresponding author
- Werner, Erika F.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2012-02-10
- Volume
- 35
- Issue
- 3
- Pages
- 529-535
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3322683
- OpenAlex
- W2171826023
- Cited by
- 182
- References
- 43
- Citations by year
- 2026: 6 · 2025: 2 · 2024: 9 · 2023: 2 · 2022: 9 · 2021: 11 · 2020: 8 · 2019: 15 · 2018: 14 · 2017: 16 · 2016: 20 · 2015: 17 · 2014: 18 · 2013: 18 · 2012: 16
- FWCI
- 26.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- gestational diabetes mellitus, IADPSG criteria, cost-effectiveness, glucose challenge test, glucose tolerance test, postpartum counseling, diabetes prevention, quality-adjusted life years, decision-analytic model
- MeSH terms
- Cost-Benefit Analysis, Female, Glucose Tolerance Test, Humans, Mass Screening, Pregnancy, Diabetes, Gestational, Quality-Adjusted Life Years
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
